Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1935 1
1957 1
1960 1
1963 1
1967 1
1972 2
1974 1
1976 1
1979 2
1980 3
1981 8
1982 11
1983 3
1984 4
1985 3
1986 3
1987 1
1988 2
1989 1
1990 3
1991 2
1992 2
1993 5
1994 6
1995 5
1996 2
1997 2
1998 1
1999 4
2000 3
2001 1
2002 8
2003 10
2004 13
2005 8
2006 17
2007 13
2008 18
2009 18
2010 23
2011 20
2012 22
2013 25
2014 12
2015 18
2016 21
2017 33
2018 21
2019 20
2020 25
2021 15
Text availability
Article attribute
Article type
Publication date

Search Results

397 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Practice Guideline for the Management of Infantile Hemangiomas.
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, Annam A, Baker CN, Frommelt PC, Hodak A, Pate BM, Pelletier JL, Sandrock D, Weinberg ST, Whelan MA; SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS. Krowchuk DP, et al. Among authors: whelan ma. Pediatrics. 2019 Jan;143(1):e20183475. doi: 10.1542/peds.2018-3475. Pediatrics. 2019. PMID: 30584062 Free article. Review.
Developing vaccines against epidemic-prone emerging infectious diseases.
Bernasconi V, Kristiansen PA, Whelan M, Román RG, Bettis A, Yimer SA, Gurry C, Andersen SR, Yeskey D, Mandi H, Kumar A, Holst J, Clark C, Cramer JP, Røttingen JA, Hatchett R, Saville M, Norheim G. Bernasconi V, et al. Among authors: whelan m. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):65-73. doi: 10.1007/s00103-019-03061-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020. PMID: 31776599 Free PMC article. Review.
Introduction.
Eskes C, Whelan M. Eskes C, et al. Among authors: whelan m. Adv Exp Med Biol. 2016;856:1-7. doi: 10.1007/978-3-319-33826-2_1. Adv Exp Med Biol. 2016. PMID: 27671717
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.
Paul Friedman K, Gagne M, Loo LH, Karamertzanis P, Netzeva T, Sobanski T, Franzosa JA, Richard AM, Lougee RR, Gissi A, Lee JJ, Angrish M, Dorne JL, Foster S, Raffaele K, Bahadori T, Gwinn MR, Lambert J, Whelan M, Rasenberg M, Barton-Maclaren T, Thomas RS. Paul Friedman K, et al. Among authors: whelan m. Toxicol Sci. 2020 Jan 1;173(1):202-225. doi: 10.1093/toxsci/kfz201. Toxicol Sci. 2020. PMID: 31532525 Free PMC article.
Advancing human health risk assessment.
Lanzoni A, Castoldi AF, Kass GE, Terron A, De Seze G, Bal-Price A, Bois FY, Delclos KB, Doerge DR, Fritsche E, Halldorsson T, Kolossa-Gehring M, Hougaard Bennekou S, Koning F, Lampen A, Leist M, Mantus E, Rousselle C, Siegrist M, Steinberg P, Tritscher A, Van de Water B, Vineis P, Walker N, Wallace H, Whelan M, Younes M. Lanzoni A, et al. Among authors: whelan m. EFSA J. 2019 Jul 8;17(Suppl 1):e170712. doi: 10.2903/j.efsa.2019.e170712. eCollection 2019 Jul. EFSA J. 2019. PMID: 32626449 Free PMC article.
397 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page